What you need to know about XBB.1.5, COVID’s latest variant
A subvariant of Omicron, XBB.1.5 spreading fast and on track to be the country's most dominant version of the virus.
Loss of muscle in COVID-19 may harm you in the long run
The more muscle mass is lost during hospitalization for COVID-19, the greater the likelihood of developing persistent symptoms of the disease.
Scientists find who are more likely to get PTSD
Understanding one's susceptibility to developing post-traumatic stress disorder (PTSD) is important.
In a study from Tufts University, scientists found a brain marker that indicates vulnerability...
COVID infection and vaccination linked to heart disease
A recent study from Cedars-Sinai confirmed the link between a debilitating heart condition and COVID-19 and, to a lesser extent, a novel link between...
How recognize, live with and prevent common heart rhythm disease
Atrial fibrillation, or AFib, is a fast and irregular heart rhythm that, left untreated, can lead to blood clots, stroke and heart failure.
It's the...
Scientists find a leading cause of death in children and young people in US
COVID-19 was the underlying cause of death for more than 940,000 people in the US, including over 1,300 deaths among children and young people...
Research shows new cause of artery hardening, kidney disease
For the longest time, clinicians have treated cardiovascular disease by focusing on diabetes and blood pressure control, reducing cholesterol using medications like aspirin and...
Scientists find new link between blood component and Parkinson’s Disease
In a study from Mater Research and elsewhere, scientists found a previously unknown genetic link between platelets and Parkinson's Disease.
They analyzed data from large-scale...
Long-lasting symptoms are common 3 months after COVID-19 positive
In a study from Yale University, scientists found long-lasting symptoms are common 3 months after testing for COVID-19.
They compared new and ongoing symptoms and...
Scientists find new drug to treat fatty liver disease
In a study from Karolinska Institutet, scientists found a drug candidate for the treatment of fatty liver.